About Amgis Lifescience Limited
Data last updated:
Amgis Lifescience Limited is a public limited company based in Vapi, Gujarat, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 22 September 1971 and has been in existence for over 55 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U99999GJ1971PLC109282. Its GSTIN is 24AABCA0226G1ZF (Gujarat).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.5 Cr. It was formerly known as Amardeep Chemicals Industries Private Limited and Amardeep Chemicals Industries Limited. It is led by directors including Yash Dharmendrabhai Patel (Whole-Time Director) and Shantaben Dharmendrabhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A/2/8 Phase I Behind Upl Vpi/013 Vapi East, Gujarat, India – 396195.
As per the financials filed for FY 2024, the company reported a revenue of ₹68.51 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹3.13 Cr (net margin 4.6%) and EBITDA of ₹11.27 Cr (EBITDA margin 16.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 23% over five years.
The company is associated with 2 brands: AMGIS Lifescience and AMGIS Lifescience Ltd. As per MCA filings, the company has open charges of ₹63.29 Cr and satisfied charges of ₹47.88 Cr on record. Court records list 9 cases involving the company, including 7 filed by the company and 2 filed against it; 4 cases are pending. The company has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹97.7 Lakh; the latest was in December 2021. Its 8 peer companies in the Pharma industry (API Manufacturers, Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Nico Orgo Marketing Private Limited with revenue of ₹70.53 Cr. The company has 5 MSME Form 1 returns on record between 2022 and 2023, listing 1,008 overdue payments to 112 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amgislifescience.com.
Company details
Name history
Amgis Lifescience has undergone 2 name changes throughout its history. The company was previously known as Amardeep Chemicals Industries Private Limited, and Amardeep Chemicals Industries Limited. The current legal name is Amgis Lifescience Limited.
| Company Name | Status |
|---|---|
| Amgis Lifescience Limited | Current |
| Amardeep Chemicals Industries Private Limited | Previous |
| Amardeep Chemicals Industries Limited | Previous |
CIN history
Amgis Lifescience has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U99999GJ1971PLC109282, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999GJ1971PLC109282 | Current |
| U99999GJ1971PTC109282 | Previous |
| U99999MH1971PTC015339 | Previous |
Contact details
Amgis Lifescience Limited's registered office is in Vapi, Gujarat. Its website is amgislifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA/2/8 Phase I Behind Upl Vpi/013 Vapi East, Gujarat, India – 396195
- IndustryPharma, Animal Pharmaceuticals & Healthcare, API Manufacturers
To see the full contact details of Amgis Lifescience Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Amgis Lifescience operates two associated brands: AMGIS Lifescience and AMGIS Lifescience Ltd. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures veterinary and human health APIs with global supply and quality assurance. | amgislifescience.com | |
| Manufacturing of Active Pharmaceutical Ingredients for veterinary and human health in India. | amardeepchemical.com |
Business activity
The main business activity of Amgis Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amgis Lifescience Limited, buy the company report.
Financials of Amgis Lifescience Limited
FY 2024 filings availableAmgis Lifescience Limited reported revenue of ₹68.51 Cr (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 13% growth in the latest year. EBITDA rose 307% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.13 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.5% | ||||
| Net Profit Margin | 4.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amgis Lifescience Limited, buy the company report.
Board of directors of Amgis Lifescience Limited
Amgis Lifescience has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shantaben Dharmendrabhai Patel | Director | 19 Aug 2016 | 10 Years 2 Months | Current |
| Dharmendrabhai Mulchandbhai Patel | Director | 19 Aug 2016 | 10 Years 2 Months | Current |
| Yash Dharmendrabhai Patel | Whole-Time Director | 06 Dec 2021 | 4 Years 11 Months | Current |
Peer comparison
Amgis Lifescience Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nico Orgo Marketing Private Limited | ₹70.53 Cr (FY 2024) | -50.0% | Kheda, Gujarat, India | |||
| Actis Generics Private Limited | ₹70.08 Cr (FY 2024) | 7.0% | Vijayawada, Andhra Pradesh, India | |||
| Vibrant Pharmachem Private Limited | ₹69.73 Cr (FY 2024) | -10.0% | Raichur, Karnataka, India | |||
| Sunlight Active Drug Ingredients Private Limited | ₹69.28 Cr (FY 2025) | -2.0% | Hyderabad, Telangana, India | |||
| Amgis Lifescience Limitedthis company | ₹68.51 Cr (FY 2024) | ₹3.13 Cr | 4.6% | 13.0% | Vapi, Gujarat, India | |
| Sanmar Speciality Chemicals Limited | ₹68.48 Cr (FY 2018) | 11.0% | Chennai, Tamil Nadu, India | |||
| Lohitha Life Sciences Private Limited | ₹67.8 Cr (FY 2024) | 7.0% | Hyderabad, Telangana, India | |||
| Vamso Biotec Private Limited | ₹67.52 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Beloorbayir Biotech Limited | ₹67.42 Cr (FY 2021) | -4.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Amgis Lifescience Limited, buy the company report.
Auditor
Amgis Lifescience Limited is audited by Rahuldeo & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rahuldeo & Co | FY 2023 | 116167W |
Shareholding
The shareholding of Amgis Lifescience Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amgis Lifescience Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Dec 2023 | 100869726 | Axis Bank Limited | ₹17.5 Cr | Open | |
| 07 May 2022 | 100586898 | Hdfc Bank Limited | ₹1.62 Cr | Open | |
| 31 Dec 2021 | 100533566 | Hdfc Bank Limited | ₹44.17 Cr | Open | |
| 28 Mar 2021 | 100444082 | Others | ₹12 Lakh | Satisfied | |
| 28 Mar 2021 | 100444083 | Others | ₹1.5 Cr | Satisfied |
To see the full charge records of Amgis Lifescience Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Amgis Lifescience Limited has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹97.7 Lakh; the latest was in December 2021.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Nov 2021 | Rights issue | ₹3.5 Cr | Investors: 2 individuals |
| Aug 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Sep 2011 | Funding round | ₹97.7 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amgis Lifescience Limited has 9 court cases on record: 7 filed by Amgis Lifescience, 2 filed against it. 4 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 2 | 4 |
Cases on record (4 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bharuch, Gujarat | Criminal complaint | Filed by the company against M/S Sri Balaji Enterprises and 1 other | Pending |
| District court, Bharuch, Gujarat | Criminal complaint | Filed by the company against M/S Markans Pharma and 1 other | Pending |
| District court, Bharuch, Gujarat | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, Bharuch, Gujarat | Court case (CR EN) | Filed by the company against M/S Markans Pharma and 1 other | Disposed |
To see the full case history of Amgis Lifescience Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Amgis Lifescience Limited has 5 MSME Form 1 returns on record between 2022 and 2023, listing 1,008 overdue payments to 112 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 112)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Micro Tech | |||
| an individual supplier | |||
| Divysai Chem Private Limited | |||
| P K Carbonics | |||
| an individual supplier |
To see the full MSME payment records of Amgis Lifescience Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Amgis Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCA0226G1ZF | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amgis Lifescience Limited, buy the company report.
Recent activity
Amgis Lifescience Limited has 8 board changes on record since 2012: 3 appointments and 5 cessations. The latest: Yash Dharmendrabhai Patel ceased to be Additional Director on 30 Sep 2022.
37 earlier events are in the company report.
Frequently asked questions
Amgis Lifescience is an active public limited company based in Vapi, Gujarat, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 22 September 1971 (55+ years old) and is registered under CIN U99999GJ1971PLC109282.
Amgis Lifescience has 3 current directors:
- Yash Dharmendrabhai Patel - Whole-Time Director
- Shantaben Dharmendrabhai Patel - Director
- Dharmendrabhai Mulchandbhai Patel - Director
The latest financial statements of Amgis Lifescience on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Amgis Lifescience is 24AABCA0226G1ZF, registered in Gujarat.
The CIN (Corporate Identification Number) of Amgis Lifescience is U99999GJ1971PLC109282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amgis Lifescience has 9 court cases on record: 7 filed by the company and 2 filed against it. 4 are pending.
Amgis Lifescience was incorporated on 22 September 1971, making it 55+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Amgis Lifescience has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹97.7 Lakh; the latest was in December 2021.
The peers of Amgis Lifescience by revenue are Nico Orgo Marketing Private Limited, Actis Generics Private Limited, Vibrant Pharmachem Private Limited, Sunlight Active Drug Ingredients Private Limited, Sanmar Speciality Chemicals Limited and 3 more, all in the Pharma industry (API Manufacturers, Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Yash Dharmendrabhai Patel ceased to be Additional Director on 30 Sep 2022. Yash Dharmendrabhai Patel was appointed as Whole-Time Director on 06 Dec 2021. Dharmendrabhai Mulchandbhai Patel was appointed as Director on 19 Aug 2016. Amgis Lifescience has 8 board changes on record in total.
Amgis Lifescience has 5 MSME Form 1 returns on record between 2022 and 2023, listing 1,008 overdue payments to 112 micro and small suppliers. The latest return was filed on 18 Dec 2023.
Amgis Lifescience can be reached through the website amgislifescience.com. Its registered office is in Vapi, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
